Antibody Drug to Protect the Vulnerable From Covid Goes Unused
The treatment could be lifesaving for many who cannot get protection from the vaccine, but confusion about the drug has made some doctors slow to […]
The treatment could be lifesaving for many who cannot get protection from the vaccine, but confusion about the drug has made some doctors slow to […]
The treatment could be lifesaving for many who cannot get protection from the vaccine, but confusion about the drug has made some doctors slow to […]
The treatment could be lifesaving for many who cannot get protection from the vaccine, but confusion about the drug has made some doctors slow to […]
The treatment could be lifesaving for many who cannot get protection from the vaccine, but confusion about the drug has made some doctors slow to […]
It’s not clear whether three doses of the Pfizer-BioNTech vaccine will adequately protect young children. But the F.D.A. may authorize the first two doses anyway.
No está claro si tres dosis de la vacuna Pfizer-BioNTech protegerán adecuadamente a los niños. Pero es posible que la FDA autorice las primeras dos […]
No está claro si tres dosis de la vacuna Pfizer-BioNTech protegerán adecuadamente a los niños. Pero es posible que la FDA autorice las primeras dos […]
It’s not clear whether three doses of the Pfizer-BioNTech vaccine will adequately protect young children. But the F.D.A. may authorize the first two doses anyway.
The antibody drug, Evusheld, was found to be strongly effective in preventing Covid in a clinical trial that enrolled mostly those at high risk.
The antibody drug, Evusheld, was found to be strongly effective in preventing Covid in a clinical trial that enrolled mostly those at high risk.
The antibody drug, Evusheld, was found to be strongly effective in preventing Covid in a clinical trial that enrolled mostly those at high risk.
Scientists in a cutting-edge laboratory do part of the work. Local health workers on foot do the rest.
A “Frankenstein mix” of mutations raises concerns, but the variant may remain vulnerable to current vaccines. If not, revisions will be necessary.
A “Frankenstein mix” of mutations raises concerns, but the variant may remain vulnerable to current vaccines. If not, revisions will be necessary.
A “Frankenstein mix” of mutations raises concerns, but the variant may remain vulnerable to current vaccines. If not, revisions will be necessary.
Una “mezcla tipo Frankenstein” de mutaciones suscita preocupación, pero la variante puede seguir siendo vulnerable a las vacunas actuales. Si no es así, serán necesarias […]
Una “mezcla tipo Frankenstein” de mutaciones suscita preocupación, pero la variante puede seguir siendo vulnerable a las vacunas actuales. Si no es así, serán necesarias […]
Una “mezcla tipo Frankenstein” de mutaciones suscita preocupación, pero la variante puede seguir siendo vulnerable a las vacunas actuales. Si no es así, serán necesarias […]
Una “mezcla tipo Frankenstein” de mutaciones suscita preocupación, pero la variante puede seguir siendo vulnerable a las vacunas actuales. Si no es así, serán necesarias […]
A “Frankenstein mix” of mutations raises concerns, but the variant may remain vulnerable to current vaccines. If not, revisions will be necessary.
A “Frankenstein mix” of mutations raises concerns, but the variant may remain vulnerable to current vaccines. If not, revisions will be necessary.
A new treatment using stem cells that produce insulin has surprised experts and given them hope for the 1.5 million Americans living with the disease.
A new treatment using stem cells that produce insulin has surprised experts and given them hope for the 1.5 million Americans living with the disease.
A new treatment using stem cells that produce insulin has surprised experts and given them hope for the 1.5 million Americans living with the disease.
A new treatment using stem cells that produce insulin has surprised experts and given them hope for the 1.5 million Americans living with the disease.
A new treatment using stem cells that produce insulin has surprised experts and given them hope for the 1.5 million Americans living with the disease.
Las autoridades sanitarias de EE. UU. autorizaron la combinación de vacunas en la dosis de refuerzo contra la covid, pero no han indicado cuál es […]
Las autoridades sanitarias de EE. UU. autorizaron la combinación de vacunas en la dosis de refuerzo contra la covid, pero no han indicado cuál es […]
Health officials approved mix-and-match Covid booster shots, but didn’t say whether it’s better to switch vaccines or stick with your original shot.
Health officials approved mix-and-match Covid booster shots, but didn’t say whether it’s better to switch vaccines or stick with your original shot.
La FDA podría autorizar dosis de refuerzo de vacunas diferentes de los que los estadounidenses recibieron en sus primeras dosis. Hay evidencia científica prometedora que […]
La FDA podría autorizar dosis de refuerzo de vacunas diferentes de los que los estadounidenses recibieron en sus primeras dosis. Hay evidencia científica prometedora que […]
The F.D.A. may authorize booster shots of vaccines different from the ones that Americans originally received. The science behind the move is promising.
The F.D.A. may authorize booster shots of vaccines different from the ones that Americans originally received. The science behind the move is promising.
Independent experts, including government scientists, were skeptical of the research from Israel, which included limited data over a short period.
Independent experts, including government scientists, were skeptical of the research from Israel, which included limited data over a short period.
Independent experts, including government scientists, were skeptical of the research from Israel, which included limited data over a short period.
Muchos de los que recibieron la vacuna pueden necesitar refuerzos, dijeron los autores. Pero las autoridades sanitarias federales no recomiendan segundas dosis.
Muchos de los que recibieron la vacuna pueden necesitar refuerzos, dijeron los autores. Pero las autoridades sanitarias federales no recomiendan segundas dosis.
Many who received the shot may need to consider boosters, the authors said. But federal health officials do not recommend second doses.
Many who received the shot may need to consider boosters, the authors said. But federal health officials do not recommend second doses.
Scientists were critical of the announcement, pointing to evidence that the current two-dose regimen is powerfully effective against the coronavirus.
Scientists were critical of the announcement, pointing to evidence that the current two-dose regimen is powerfully effective against the coronavirus.
France is handing out third shots of the two-dose vaccines to cancer patients and others with immune system impairments. In the United States, patients like […]
France is handing out third shots of the two-dose vaccines to cancer patients and others with immune system impairments. In the United States, patients like […]
Young adults are avoiding shots, threatening the U.S. recovery.
Young adults are avoiding shots, threatening the U.S. recovery.
Young adults are avoiding shots, threatening the U.S. recovery.
Many cannot produce enough infection-fighting cells to fend off the coronavirus. But researchers are testing one therapy that may help: monoclonal antibodies.
Many cannot produce enough infection-fighting cells to fend off the coronavirus. But researchers are testing one therapy that may help: monoclonal antibodies.
Many cannot produce enough infection-fighting cells to fend off the coronavirus. But researchers are testing one therapy that may help: monoclonal antibodies.
Una nueva formulación que está entrando en ensayos clínicos en Brasil, México, Tailandia y Vietnam podría cambiar la forma en que el mundo combate la […]
Una nueva formulación que está entrando en ensayos clínicos en Brasil, México, Tailandia y Vietnam podría cambiar la forma en que el mundo combate la […]
A new formulation entering clinical trials in Brazil, Mexico, Thailand and Vietnam could change how the world fights the pandemic.
A new formulation entering clinical trials in Brazil, Mexico, Thailand and Vietnam could change how the world fights the pandemic.
A new formulation entering clinical trials in Brazil, Mexico, Thailand and Vietnam could change how the world fights the pandemic.
The company’s coming trials will also involve pregnant women and people whose immune systems are compromised.
The company’s coming trials will also involve pregnant women and people whose immune systems are compromised.
The company’s coming trials will also involve pregnant women and people whose immune systems are compromised.
Scientists are exploring the physics of viruses, to understand how these pathogens assemble themselves — and might be rent apart.
Scientists are exploring the physics of viruses, to understand how these pathogens assemble themselves — and might be rent apart.
Scientists are exploring the physics of viruses, to understand how these pathogens assemble themselves — and might be rent apart.
Scientists are exploring the physics of viruses, to understand how these pathogens assemble themselves — and might be rent apart.
The big dip in mortality shown in the trial of about 800 patients has caught some experts by surprise because previous studies of the drugs […]
The big dip in mortality shown in the trial of about 800 patients has caught some experts by surprise because previous studies of the drugs […]
The patient, who has a severe shellfish allergy, recovered quickly with treatment. Until now, reports of severe reactions had been linked to the Pfizer vaccine.
The patient, who has a severe shellfish allergy, recovered quickly with treatment. Until now, reports of severe reactions had been linked to the Pfizer vaccine.
Four people so far have had allergic reactions after getting the Pfizer-BioNTech vaccine. Experts say that shouldn’t deter most people from getting a jab.
Copyright © 2024 | WordPress Theme by MH Themes